Cntn6 has been identified as a candidate risk gene of multiple psychiatric disorders including autism spectrum disorders (ASDs), schizophrenia, bipolar disorder, attention‐deficit hyperactivity disorder, intellectual disability, and Tourette syndrome (Guo et al., 2012; Hu et al., 2015; Huang et al., 2017; Kashevarova et al., 2014; Kerner, Lambert, & Muthen, 2011; Nava et al., 2014; Oguro‐Ando, Zuko, Kleijer, & Burbach, 2017; Okbay et al., 2016; Pinto et al., 2010; Van Daalen et al., 2011), suggesting the necessity of CNTN6 in neural development. The gene discussed is CNTN6; the disease is autism spectrum disorder.